Neuropathologic changes in Alzheimer's disease: potential targets for treatment.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Clinical Psychiatry

• Publication date

  2006-03-15

• Fields of study

  Medicine

• Identifiers
  PMID 16649845
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease.

  2006cited by this paper
• Memantine in Moderate-to-severe Alzheimer's Disease

  2006cited by this paper
• Diagnosis and treatment of Alzheimer’s disease

  2005cited by this paper
• Mitochondrial aging and dysfunction in Alzheimer's disease.

  2005cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Diagnosis and treatment of Alzheimer's disease.

  2003cited by this paper
• Memantine in moderate-to-severe Alzheimer's disease.

  2003cited by this paper
• Progressive degeneration of nonphosphorylated neurofilament protein‐enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: Stereologic analysis of prefrontal cortex area 9

  2003cited by this paper
• The Amygdala and Alzheimer's Disease

  2003cited by this paper
• The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenase-2 inhibition

  2000cited by this paper
• Inflammation and Alzheimer's disease.

  2000cited by this paper
• Memantine in severe dementia: results of the 9M‐best study (benefit and efficacy in severly demented patients during treatment with memantine)

  1999cited by this paper
• Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging.

  1996cited by this paper
• Neurodegeneration mediated by glutamate and beta-amyloid peptide: a comparison and possible interaction.

  1995cited by this paper
• Neurodegeneration mediated by glutamate and β-amyloid peptide: a comparison and possible interaction

  1995cited by this paper
• AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function

  1994cited by this paper
• Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists.

  1993cited by this paper
• The medial temporal lobe memory system

  1991cited by this paper
• Selective fimbria lesions impair acquisition of working and reference memory of rats in a complex spatial discrimination task.

  1989cited by this paper
• Place navigation in rats is impaired by lesions of medial septum and diagonal band but not nucleus basalis magnocellularis.

  1988cited by this paper
• Presynaptic Cholinergic Dysfunction in Patients with Dementia

  1983cited by this paper
• The molecular forms of cholinesterase and acetylcholinesterase in vertebrates.

  1982cited by this paper
• Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain.

  1982cited by this paper
• The cholinergic hypothesis of geriatric memory dysfunction.

  1982cited by this paper
• CHANGES IN BRAIN CHOLINESTERASES IN SENILE DEMENTIA OF ALZHEIMER TYPE

  1978cited by this paper
• Materials and Methods Som Text Figs. S1 and S2 Table S1 References Abad Directly Links A␤ to Mitochondrial Toxicity in Alzheimer's Disease

  year unknowncited by this paper

• Stilbenes Against Alzheimer’s Disease: A Comprehensive Review of Preclinical Studies of Natural and Synthetic Compounds Combined with the Contributions of Developed Nanodrug Delivery Systems

  2025cites this paper
• Altered intrinsic ignition dynamics linked to Amyloid-β and tau pathology in Alzheimer’s disease

  2024cites this paper
• A Molecular Communication Perspective of Alzheimer’s Disease: Impact of Amyloid Beta Oligomers on Glutamate Diffusion in the Synaptic Cleft

  2024cites this paper
• Psychedelics for Alzheimer's Disease-Related Dementia: Unveiling Therapeutic Possibilities and Pathways.

  2024cites this paper
• Diabetes Mellitus and Alzheimer's Disease: Understanding Disease Mechanisms, their Correlation, and Promising Dual Activity of Selected Herbs.

  2024cites this paper
• Latest advances in mechanisms of epileptic activity in Alzheimer’s disease and dementia with Lewy Bodies

  2024cites this paper
• A Cholecystokinin Analogue Ameliorates Cognitive Deficits and Regulates Mitochondrial Dynamics via the AMPK/Drp1 Pathway in APP/PS1 Mice

  2024cites this paper
• Changes of tRNA-Derived Fragments by Alzheimer’s Disease in Cerebrospinal Fluid and Blood Serum

  2023cites this paper
• Constituents of Stachys plants as potential dual inhibitors of AChE and NMDAR for the treatment of Alzheimer’s disease: a molecular docking and dynamic simulation study

  2023cites this paper
• Whole-brain modeling of the differential influences of amyloid-beta and tau in Alzheimer’s disease

  2023cites this paper
• Comparison of Emotion Recognition in Young People, Healthy Older Adults, and Patients with Mild Cognitive Impairment

  2022cites this paper
• Biological Potential, Gastrointestinal Digestion, Absorption, and Bioavailability of Algae-Derived Compounds with Neuroprotective Activity: A Comprehensive Review

  2022cites this paper
• Prominent gamma band activity during visual motion perception in early-stage Alzheimer’s disease

  2022cites this paper
• Rhein Ameliorates Cognitive Impairment in an APP/PS1 Transgenic Mouse Model of Alzheimer's Disease by Relieving Oxidative Stress through Activating the SIRT1/PGC-1α Pathway

  2022cites this paper
• Recent insights into the roles of circular RNAs in human brain development and neurologic diseases.

  2022cites this paper
• Asymmetry-enhanced attention network for Alzheimer's diagnosis with structural Magnetic Resonance Imaging

  2022cites this paper
• Single Cell/Nucleus Transcriptomics Comparison in Zebrafish and Humans Reveals Common and Distinct Molecular Responses to Alzheimer’s Disease

  2022cites this paper
• Novel strategies for the fight of Alzheimer’s disease targeting amyloid-β protein

  2021cites this paper
• The Role of D-Amino Acids in Alzheimer’s Disease

  2021cites this paper
• Serum d-serine levels are altered in early phases of Alzheimer’s disease: towards a precocious biomarker

  2021cites this paper
• A mechanistic survey of Alzheimer's disease.

  2021cites this paper
• Functional roles of the microbiota-gut-brain axis in Alzheimer’s disease: Implications of gut microbiota-targeted therapy

  2021cites this paper
• In-Silico Study of Some Natural Plant Phyto-compounds for the Identification of Novel Potent Cholinesterase Inhibitors Against Alzheimer Disease

  2021cites this paper
• Beta Amyloid, Tau Protein, and Neuroinflammation: An Attempt to Integrate Different Hypotheses of Alzheimer’s Disease Pathogenesis

  2021cites this paper
• Regulation of Melatonin and Neurotransmission in Alzheimer’s Disease

  2021cites this paper
• Galantamine Delivery for Alzheimer’s Disease

  2020cites this paper
• Osthole ameliorates cognitive impairments via augmenting neuronal population in APP / PS1 transgenic mice.

  2020cites this paper
• Functional roles of circular RNAs in Alzheimer's disease.

  2020cites this paper
• CIRBP Ameliorates Neuronal Amyloid Toxicity via Antioxidative and Antiapoptotic Pathways in Primary Cortical Neurons

  2020cites this paper
• Genus Boswellia as a new candidate for neurodegenerative disorders

  2020cites this paper
• Regulation of membrane NMDA receptors by dynamics and protein interactions

  2020cites this paper
• Association between chronic stress and Alzheimer's disease: Therapeutic effects of Saffron.

  2020cites this paper
• A new naphthalene derivative with anti-amyloidogenic activity as potential therapeutic agent for Alzheimer's disease.

  2020cites this paper
• Analysis of brain region-specific co-expression networks reveals clustering of established and novel genes associated with Alzheimer disease

  2020cites this paper
• Therapeutic potentials of neural stem cells in Alzheimer's disease.

  2020cites this paper
• Microglial Sirtuin 2 Shapes Long-Term Potentiation in Hippocampal Slices

  2020cites this paper
• Sustainable Agriculture Reviews 43: Pharmaceutical Technology for Natural Products Delivery Vol. 1 Fundamentals and Applications

  2020cites this paper
• Scope of new formulation approaches in the repurposing of pioglitazone for the management of Alzheimer’s disease

  2019cites this paper
• The dual face of glutamate: from a neurotoxin to a potential survival factor—metabolic implications in health and disease

  2019cites this paper
• Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies

  2019cites this paper
• Receptores neurais e a doença de Alzheimer: uma revisão sistemática da literatura sobre as famílias de receptores mais associadas a doença, suas funções e áreas de expressão

  2019cites this paper
• Dementia 2. Alzheimer's disease: diagnosis, treatment and managment

  2019cites this paper
• Dementia: prevalence and pathophysiology

  2019cites this paper
• Prospective of managing impaired brain insulin signalling in late onset Alzheimers disease with excisting diabetic drugs

  2019cites this paper
• Is Alzheimer's disease linked to Herpes simplex virus type 1 infection? A mini‐review of the molecular correlation and the possible disease connections

  2019cites this paper
• The effects of aerobic training before and after the induction of Alzheimer’s disease on ABCA1 and APOE mRNA expression and the level of soluble Aβ1-42 in the hippocampus of male Wistar rats

  2019cites this paper
• The Role of NMDA Receptors in Alzheimer’s Disease

  2019influential citation
• In vitro and in silico approaches to appraise Polygonum maritimum L. as a source of innovative products with anti-ageing potential

  2018cites this paper
• Towards miniaturized closed-loop optogenetic stimulation devices

  2018cites this paper
• Acid-base fractions separated from Streblus asper leaf ethanolic extract exhibited antibacterial, antioxidant, anti-acetylcholinesterase, and neuroprotective activities

  2018cites this paper
• Alzheimer's disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline

  2018cites this paper
• NEUROPSYCHIATRIC-LIKE BEHAVIOURAL FEATURES OF THE ALDH 2-/-MOUSE MODEL OF ALZHEIMER ’ S DISEASE by

  2018cites this paper
• Downregulation of Aquaporin 9 Exacerbates Beta-amyloid-induced Neurotoxicity in Alzheimer's Disease Models In vitro and In vivo.

  2018cites this paper
• Losing connections in Alzheimer disease : the amyloid precursor protein processing machinery at the synapse

  2018cites this paper
• Sea rose (Armeria pungens (Link) Hoffmanns. & Link) as a potential source of innovative industrial products for anti-ageing applications

  2018cites this paper
• Synthesis and cholinesterase inhibitory activity study of new piperidone grafted spiropyrrolidines.

  2017cites this paper
• Biomechanistic insights into the roles of oxidative stress in generating complex neurological disorders

  2017cites this paper
• Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential

  2017cites this paper
• Molecular Pathogenesis of Alzheimer's Disease: An Update

  2017cites this paper
• Combining in silico and in vitro approaches to evaluate the acetylcholinesterase inhibitory profile of some commercially available flavonoids in the management of Alzheimer's disease.

  2017cites this paper
• Toxicity evaluation of two polyoxotungstates with anti‐acetylcholinesterase activity

  2017cites this paper
• Design and synthesis of new piperidone grafted acetylcholinesterase inhibitors.

  2017cites this paper
• University of Groningen The basal forebrain cholinergic system in aging and dementia

  2017cites this paper
• New Therapeutic Targets in Alzheimer's Disease

  2017cites this paper
• DISEASE PROGRESSION AND TREATMENT STRATEGIES FOR THE MANAGEMENT OF ALZHEIMER’S DISEASE: AN OVERVIEW

  2017cites this paper
• Mesenchymal Stem Cells of Dental Origin-Their Potential for Anti-inflammatory and Regenerative Actions in Brain and Gut Damage

  2016cites this paper
• Učestalost anksioznih i depresivnih simptoma kod obiteljskih i profesionalnih njegovatelja koji skrbe o oboljelima od Alzheimerove bolesti

  2016cites this paper
• The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease.

  2016cites this paper
• Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition Mode.

  2016cites this paper
• The Relieving Effects of BrainPower Advanced, a Dietary Supplement, in Older Adults with Subjective Memory Complaints: A Randomized, Double-Blind, Placebo-Controlled Trial

  2016cites this paper
• Neural stem/progenitor cells in Alzheimer’s disease

  2016cites this paper
• Alzheimer’s disease in people with Down’s syndrome: the prospects for and the challenges of developing preventative treatments

  2016cites this paper
• Role of Glutamate and NMDA Receptors in Alzheimer’s Disease

  2016cites this paper
• Neurological Disease as a Failure of Brain-Immune Crosstalk: The Multiple Faces of Neuroinflammation.

  2016cites this paper
• The Role of Stem Cell Therapy in Alzheimer’s Disease

  2016cites this paper
• Analysis of calretinin early expression in the rat hippocampus after beta amyloid (1-42) peptide injection.

  2015cites this paper
• Altered Neurotransmission Prior to Cognitive Decline in AβPP/PS1 Mice, a Model of Alzheimer's Disease

  2015cites this paper
• Molecular Mechanisms of Drug-Induced Cognitive Enhancement

  2015cites this paper
• In vitro Evaluation of Acacia nilotica Pods for its Antioxidant , Acetylcholinesterase Inhibitory Activities and Phytochemical Screening

  2015influential citation
• The role of diet, erythrocyte membrane fatty acid composition, and Alzheimer's- related genes in systemic inflammation in the Cache County Memory Study

  2015cites this paper
• Alzheimer Disease: The Role of Aβ in the Glutamatergic System

  2014cites this paper
• Tyrosinase, Acetylcholinesterase Inhibitory Potential, Antioxidant and Antimicrobial Activities of Sponge Derived Fungi with correlation to their GC/MS Analysis

  2014cites this paper
• Analysis of spatio‐temporal brain imaging patterns by hidden markov models and serial MRI images

  2014cites this paper
• Analysis of central mechanism of cognitive training on cognitive impairment after stroke: Resting-state functional magnetic resonance imaging study

  2014cites this paper
• ANTICHOLINESTERASE EFFECT OF SOYBEAN EXTRACT ( GLYCINE MAX L.) IN THE BRAIN OF AMNESIC MICE AND ITS PROTECTIVE EFFECTS AGAINST BETAAMYLOID INDUCED CYTOTOXICITY IN PC12 CELLS

  2014cites this paper
• Memantine prevents reference and working memory impairment caused by sleep deprivation in both young and aged Octodon degus.

  2014cites this paper
• Melatonin Premedication Attenuates Isoflurane Anesthesia-Induced β-Amyloid Generation and Cholinergic Dysfunction in the Hippocampus of Aged Rats

  2013cites this paper
• Metabolic Syndrome as a Risk Factor for Alzheimer Disease

  2013cites this paper
• Effect of Polygala radix Hot Water Extract on Biological Activity in PC12 Cells

  2013cites this paper
• Secretory Sorting Receptors Carboxypeptidase E and Secretogranin III in Amyloid β‐Associated Neural Degeneration in Alzheimer's Disease

  2013cites this paper
• Effects of memantine and galantamine on cognitive performance in aged rhesus macaques.

  2013cites this paper
• Calidad de vida, cuidadores e intervención para la mejora de la salud en el envejecimiento

  2013cites this paper
• PREVALENCIA DEL SÍNDROME DISEJECUTIVO Y SU RELACIÓN CON

  2013cites this paper
• Metabolic Syndrome

  2013cites this paper
• Effectiveness and safety of generic memantine hydrochloride manufactured in China in the treatment of moderate to severe Alzheimer's disease: a multicenter, double-blind randomized controlled trial

  2013cites this paper
• Mechanism Linking Cognitive Impairment and Diabetes mellitus

  2013cites this paper
• Activation of immobility‐related hippocampal theta by cholinergic septohippocampal neurons during vestibular stimulation

  2012cites this paper
• 6 Recent Developments in Molecular Changes Leading to Alzheimer ’ s Disease and Novel Therapeutic Approaches

  2012cites this paper
• Synergistic Effects of Antidementia Drugs on Spatial Learning and Recall in the APP23 Transgenic Mouse Model of Alzheimer's Disease

  2012cites this paper
• Alzheimer's disease, β‐amyloid, glutamate, NMDA receptors and memantine – searching for the connections

  2012cites this paper